CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
批准号:
3145434
负责人:
RANDALL J. COHRS
金额:
$13.5万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-04-01 至 1993-03-31
关键词:
DNA RNA RNA splicing antisense nucleic acid double stranded RNA electrophoresis enzyme complex glucocorticoids interferons microinjections molecular cloning natural gene amplification nucleic acid hybridization nucleic acid metabolism pancreatic ribonuclease plasmids temperature sensitive mutant tissue /cell culture transfection vaccinia virus virus genetics virus replication
中文摘要
RNA周转是基因表达调控的核心;然而,
英文摘要
RNA turnover is central to the regulation of gene expression; however, the
mechanisms involved are not well understood. The temperature sensitive
mutant of vaccinia virus, ts22, provides a genetic tool for elucidating
mechanism(s) involved in RNA turnover. The ts22 gene regulates the
stability of RNA in vaccinia virus infected cells. ts22 virus has an
abortive late phenotype. At the non-permissive temperature, ts22 infection
proceeds normally in the early stages; however, at 8-10 h post infection,
RNA is degraded and virus infection aborted (independent of exogenous
interferon treatment). Our results indicate that the degradation of RNA is
due to the activation of 2-5A dependent RNase. 2-5A synthetase-RNase
pathway, initially discovered as one of the antiviral mechanisms of
interferon, has been implicated in controlling RNA turnover during cell
growth, hormone status and differentiation. The ability to modulate the 2-
5A pathway would be of value in assessing its role in RNA degradation. We
hypothesize that the functional ts22 gene product inactivates the 2-5A
system during productive infection. Inactivation of the 2-5A pathway by
expression of the functional ts22 gene product, independent of virus
infection, should help elucidate the role of 2-5A pathway in cellular RNA
turnover. We propose to study the modulation of 2-5A pathway by ts22 gene
product. This will be accomplished by determining the growth of ts22
vaccinia virus and rRNA cleavage (an indicator of activation of the 2-5A
system) at the non-permissive temperature, in cells in which the 2-5A
pathway has been rendered inoperative. Constitutive expression of the
functional ts22 gene product will be tested for its ability to inactivate
the 2-5A system. The step(s) at which the ts22 gene product inactivates
the 2-5A system will be determined. Further use of vectors expressing the
wild type ts22 gene or 2-5A synthetase antisense RNA should permit the
assessment of the role of the 2-5A system in controlling RNA degradation
during cell growth inhibition and we will determine effect of these vectors
on the interferon or glucocorticoid induced growth inhibition and reduction
in c-myc expression in Daudi cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevention of VZV Reactivation
-
批准号:8476910
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Prevention of VZV Reactivation
-
批准号:8617880
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Prevention of VZV Reactivation
-
批准号:8794483
-
项目类别:
-
资助金额:$33.97万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Prevention of VZV Reactivation
-
批准号:9208821
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:10343676
-
项目类别:
-
资助金额:$43.82万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:9491548
-
项目类别:
-
资助金额:$45.02万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:10542746
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:10097966
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Varicella Zoster Virus Latency in Human Ganglia
-
批准号:6746034
-
项目类别:
-
资助金额:$33.12万
-
财政年份:2003
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6565246
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2001
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6410649
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2000
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6302840
-
项目类别:
-
资助金额:$26.91万
-
财政年份:1999
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6346297
-
项目类别:
-
资助金额:$24.29万
-
财政年份:1999
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6112506
-
项目类别:
-
资助金额:$26.91万
-
财政年份:1998
-
负责人:RANDALL J. COHRS
-
依托单位:
CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
-
批准号:3145433
-
项目类别:
-
资助金额:$13.96万
-
财政年份:1990
-
负责人:RANDALL J. COHRS
-
依托单位:
CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
-
批准号:3145435
-
项目类别:
-
资助金额:$14.46万
-
财政年份:1990
-
负责人:RANDALL J. COHRS
-
依托单位:
Varicella Zoster Virus Latency in Human Ganglia
-
批准号:7425976
-
项目类别:
-
资助金额:$38.38万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
ROLE OF VZV IE63 IN VZV LATENCY AND REACTIVATION
-
批准号:8377749
-
项目类别:
-
资助金额:$33.42万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
Varicella Zoster Virus Latency in Human Ganglia
-
批准号:7214717
-
项目类别:
-
资助金额:$35.24万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
ROLE OF VZV IE63 IN VZV LATENCY AND REACTIVATION
-
批准号:8230848
-
项目类别:
-
资助金额:$33.41万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
RNA结合蛋白SORBS2调控AIM2通路介导内皮焦亡促肺动脉高压血管重构的作用与机制研究
-
批准号:2026JJ50099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: